Next PLC
19 November 2007
Next plc
Off-market purchases by way of contingent purchase contract by the Company of
ordinary shares for cancellation
Next plc announces today that, pursuant to the contingent forward purchase
contract with Goldman Sachs International on 25 June 2007, it has today
purchased 50,000 ordinary shares for cancellation at a price of 1930.96 pence
per share.
A J R McKinlay
Company Secretary
Next plc
Editorial note:
Under the contingent contract, the Company may purchase a fixed number of shares
each week in the period to 21 January 2008 (excluding 24 and 31 December 2007
and 7 January 2008), at a fixed price that is at a discount to the market price
prevailing at the start of the contract period. The contract is contingent in
that it would terminate early, and no further shares would be purchased, if the
Company's share price increases to a pre-determined suspension level during the
contract period. This suspension level has been set at the start of the contract
and is between 104% and 110% of the Company's share price at the start of the
contract.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.